Maryl Kreider, M.D., M.S.

Assistant Professor

University of Pennsylvania Medical Center
Pulmonary, Allergy & Critical Care Division
828 West Gates Building
3600 Spruce Street
Philadelphia, PA 19104

tel.: (215) 614-1939
fax: (215) 614-0869
email: kreiderm@mail.med.upenn.edu

Education:

M.D.: University of Pennsylvania

M.S.C.E.: University of Pennsylvania

Fellowship: Hospital of the University of Pennsylvania

Dr. Kreider is the Co- Director of the Interstitial Lung Disease Program and has expertise in the evaluation and treatment of patients with diffuse parenchymal lung diseases. Additionally, she is the Medical Director of the Pulmonary Diagnostics Laboratory of the Hospital of the University of Pennsylvania. Dr. Kreider’s clinical interests include patients with Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis associated with Collagen Vascular Disease, Chronic Hypersensitivity Pneumonitis and Sarcoidosis. A recipient of a Masters degree in Clinical Epidemiology and Biostatistics, Dr. Kreider studies risk factors for both the development of Interstitial Lung Diseases and for poor outcome. She is an active participant in several drug trials for patients both with pulmonary fibrosis and sarcoidosis

Representative publications:

Dine CJ, Kreider ME. “Pulmonary Complications of Anti-Rheumatic Therapy.” Clinical Pulmonary Medicine (in press).

Lange N, Mulholland M, Kreider ME. “Spirometry: Don’t Blow It.” Chest. (in press)

Kreider ME, Kotloff RM. “Selection of Candidate for Lung Transplantation.” Proceedings of the American Thoracic Society  6:20-27(2009)

Dine CJ, Kreider ME, Hypoxia Altitude Simulation Testing, Chest 133: 1002-1005 (2008).

Munson JC, Kreider ME. The Role of Surgical Biopsy in the Evaluation of Interstitial Lung Disease, Clinical Pulmonary Medicine 15: 201-209 (2008).

Kreider ME, Rossman MD. Beryllium and Hard Metal Lung Disease. Fishman’s Textbook of Pulmonary Diseases and Disorders, 4th edition, McGraw Hill Press, New York, (2008).

Kreider ME, Rossman MD. Lessons Learned From ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proceedings of the American Thoracic Society 4:453-6 (2007).

Kreider ME, Grippi MA, Impact of the new ATS/ERS pulmonary function test interpretation guidelines. Respir Med 101: 2336-2342 (2007).

Kreider ME, Hansen-Flaschen J, Ahmad N, Rossman MD, Kaiser L, Kucharczuk J, Shrager J. Complications of Video- Assisted Thoracoscopic Lung Biopsy in Patients with Interstitial Lung Disease. Annals of Thoracic Surgery, 83:1140-4 (2007).

Kreider ME, Christie J, Thompson B, Newman LS, Rose C, Barnard JA, Bresnitz E, Judson MA, Lackland D, and Rossman M. Environmental exposures and the clinical phenotype of sarcoidosis. Chest, 128:207-15 (2005).

Kreider ME, Rossman, MD. HLA and Sarcoidosis. Sarcoidosis, Volume 210, Lung Biology in Health and Disease, Taylor and Francis, New York, (2006).

 

reviseed 8/09